These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2561985)

  • 21. Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).
    Tanaka T; Ito M; Ohmura T; Hidaka H
    Biochemistry; 1985 Sep; 24(19):5281-4. PubMed ID: 3000429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Full activation without calmodulin of calmodulin-dependent cyclic nucleotide phosphodiesterase by acidic glycosphingolipids: GM3, sialosylneolactotetraosylceramide and sulfatide.
    Higashi H; Yamagata T
    FEBS Lett; 1992 Dec; 314(1):53-7. PubMed ID: 1333416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
    Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
    Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
    Reeves ML; Leigh BK; England PJ
    Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
    Drees M; Zimmermann R; Eisenbrand G
    Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calmodulin interacts with cyclic nucleotide phosphodiesterase and calcineurin by binding to a metal ion-independent hydrophobic region on these proteins.
    Gopalakrishna R; Anderson WB
    J Biol Chem; 1983 Feb; 258(4):2405-9. PubMed ID: 6296146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A derivative of bisbenzylisoquinoline alkaloid is a new and potential calmodulin antagonist.
    Xu YH; Zhang SP
    Biochem Biophys Res Commun; 1986 Oct; 140(1):461-7. PubMed ID: 3022722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of cyclic peptides and depsipeptides with calmodulin.
    Mereish KA; Solow R; Bunner DL; Fajer AB
    Pept Res; 1990; 3(5):233-7. PubMed ID: 1724618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.
    Sugden MC; Ashcroft SJ
    Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cells.
    Watz MA; Holt IL; Howlett AC
    J Neurosci Res; 1987; 17(3):291-7. PubMed ID: 3037096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimers of anionic amphiphiles mimic calmodulin stimulation of cyclic nucleotide phosphodiesterase.
    Gietzen K; Xü YH; Galla HJ; Bader H
    Biochem J; 1982 Dec; 207(3):637-40. PubMed ID: 6299276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interaction of calcium agonists and antagonists with Ca-binding proteins and their effect on cyclic nucleotide phosphodiesterase].
    Feoktistov IA; Baldenkov GN; Barannik IV; Cherviakov EB; Larionov NP
    Biokhimiia; 1990 Apr; 55(4):754-9. PubMed ID: 2165822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin.
    Schaeffer P; Luginer C; Follenius-Wund A; Gerard D; Stoclet JC
    Biochem Pharmacol; 1987 Jun; 36(12):1989-96. PubMed ID: 3036157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
    Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
    Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase by Triton X-100.
    Sharma RK; Wang JH
    Biochem Biophys Res Commun; 1981 May; 100(2):710-5. PubMed ID: 6268071
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of cyclic nucleotide phosphodiesterase and calmodulin in the small intestinal mucosa of rabbits].
    Iurkov VA
    Biull Eksp Biol Med; 1981 Jul; 92(7):91-4. PubMed ID: 6271290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular properties of cyclic nucleotide phosphodiesterase isozymes.
    Strada SJ; Kithas PA; Whalin ME; Thompson WJ
    Adv Exp Med Biol; 1989; 255():409-23. PubMed ID: 2559603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of a cyclic nucleotide phosphodiesterase and of a protein kinase by chemically modified calmodulin.
    Tertrin-Clary C; Chenut MC; de la Llosa P
    Int J Biochem; 1987; 19(10):949-55. PubMed ID: 2822504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.
    Rowlands MG; Grimshaw R; Jarman M; Bouhoute A; Leclercq G
    Biochem Pharmacol; 1997 Jan; 53(2):241-4. PubMed ID: 9037257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.